The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms

Rizzo, 1989, Collagen types and matrix protein content in human abdominal aortic aneurysms, J Vasc Surg, 10, 365, 10.1016/0741-5214(89)90409-6

Sumner, 1970, Stress-strain characteristics and collagen-elastin content of abdominal aortic aneurysms, Surg Gynecol Obstet, 130, 459

Baxter, 1994, Abdominal aortic aneurysms are associated with altered matrix proteins of the nonaneurysmal aortic segments, J Vasc Surg, 19, 797, 10.1016/S0741-5214(94)70004-4

Newman, 1994, Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm, Arterioscler Thromb, 14, 1315, 10.1161/01.ATV.14.8.1315

McMillan, 1995, In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta, Arterioscler Thromb Vasc Biol, 15, 1139, 10.1161/01.ATV.15.8.1139

McMillan, 1995, In situ localization and quantification of seventy-two–kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta, J Vasc Surg, 22, 295, 10.1016/S0741-5214(95)70144-3

Brophy, 1991, The role of inflammation in nonspecific abdominal aortic aneurysm disease, Ann Vasc Surg, 5, 229, 10.1007/BF02329378

Elmore, 1998, Expression of matrix metalloproteinases and TIMPs in abdominal aortic aneurysms, Ann Vasc Surg, 12, 221, 10.1007/s100169900144

Newman, 1994, Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall, J Vasc Surg, 20, 814, 10.1016/S0741-5214(94)70169-5

Brophy, 1991, Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report, J Surg Res, 50, 653, 10.1016/0022-4804(91)90058-T

Tamarina, 1997, Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta, Surgery, 122, 264, 10.1016/S0039-6060(97)90017-9

Anidjar, 1990, Elastase-induced experimental aneurysms in rats, Circulation, 82, 973, 10.1161/01.CIR.82.3.973

Anidjar, 1992, Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms, J Vasc Surg, 16, 139, 10.1016/0741-5214(92)90101-D

Anidjar, 1994, Experimental study of determinants of aneurysmal expansion of the abdominal aorta, Ann Vasc Surg, 8, 127, 10.1007/BF02018860

Halpern, 1994, The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response, J Vasc Surg, 20, 51, 10.1016/0741-5214(94)90175-9

Petrinec, 1996, Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase, J Vasc Surg, 23, 336, 10.1016/S0741-5214(96)70279-3

Rasmussen, 1997, Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat, Pharmacol Ther, 75, 69, 10.1016/S0163-7258(97)00023-5

Taraboletti, 1995, Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases, J Natl Cancer Inst, 87, 293, 10.1093/jnci/87.4.293

Newman, 1994, Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources, Connect Tissue Res, 30, 265, 10.3109/03008209409015042

Knox, 1997, Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases, Circulation, 95, 205, 10.1161/01.CIR.95.1.205

Holmes, 1996, Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat, J Surg Res, 63, 305, 10.1006/jsre.1996.0265